Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy
Proteolysis
Degradation
DOI:
10.1039/d3tb03046f
Publication Date:
2024-02-21T04:01:01Z
AUTHORS (7)
ABSTRACT
Proteolysis targeting chimeras (PROTACs) is a promising strategy for cancer therapy. However, the always-on bioactivity of PROTACs may lead to non-target toxicity, which restricts their antitumor performance. Here, we developed an X-ray radiation responsive PROTAC nanomicelle (RCNprotac) by covalently conjugating reported small molecule (MZ1) hydrophilic PEG
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....